EOM 1352: Fri 7 June 2024, 11:36

Current Edition

ramusmedical
Clinical Development in Challenging Cancers: Ovarian Clear Cell Carcinoma (OCCC)
Volume 10 Issue 2

Clinical Development in Challenging Cancers: Ovarian Clear Cell Carcinoma (OCCC)

Ovarian clear cell carcinoma (OCCC) is a rare histological subtype of epithelial ovarian cancers (EOCs), with an incidence, among EOCs, of 4–12% in western countries ...
Continue Reading →
Immune Mediated Inflammatory Diseases (IMIDs) and Unmet Medical Need
Volume 10 Issue 2

Immune Mediated Inflammatory Diseases (IMIDs) and Unmet Medical Need

Our immune system is extremely complex and is of great value for our health. HIV and its destruction of the immune system is clear evidence. Many researchers have lon...
Continue Reading →
Why the Need for Centralised Content Management is on the Rise
Volume 10 Issue 2

Why the Need for Centralised Content Management is on the Rise

Despite the advances in electronic content management over the past decade, many of the biggest global life sciences companies still manage their local translations i...
Continue Reading →
How Integrated Technology Benefits Patients and Investigators in Diabetes Clinical Trials
Volume 10 Issue 2

How Integrated Technology Benefits Patients and Investigators in Diabetes Clinical Trials

Doctors are warning of the ‘absolute pandemic’ of diabetes. In the US alone, 100 million are diagnosed with diabetes, with many millions more undiagnosed or unaware o...
Continue Reading →
Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis. Part 2: Considerations for Planning and Conducting Clinical Trials
Volume 10 Issue 2

Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis. Part 2: Considerations for Planning and Conducting Clinical Trials

Nonalcoholic fatty liver disease (NAFLD) is a widespread cause of chronic liver disease (CLD) and liver-related morbidity and mortality, and is the most common cause ...
Continue Reading →
Quotient